Product Reports Resources Pricing Login Book a demo

Arzeda

Biotech & Life Sciences · Seattle, United States · Founded 2008

Develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production MoreLess

Arzeda is a biotechnology company specializing in the computational design of proteins to create sustainable and high-performance chemicals. Operating in the industrial biotechnology market, Arzeda serves clients across various sectors including chemicals, materials, and consumer goods. The company's business model revolves around leveraging its proprietary technology to design custom proteins and fermentation strains, enabling the production of novel molecules that are otherwise inaccessible through natural diversity or synthetic chemistry. Arzeda generates revenue through partnerships, licensing agreements, and collaborative projects with industry leaders such as Unilever and Amyris. By optimizing and differentiating bioproducts, Arzeda aims to improve economic efficiency and market penetration for its clients. Keywords: computational protein design, sustainable chemicals, biotechnology, industrial production, enzyme design, fermentation strains, novel molecules, partnerships, licensing, market differentiation.

Company overview

Arzeda company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2008
Headquarters
Seattle, United States
Employees
76
Open positions
1
Dealroom signal
83.2
client focusb2btechnologyArtificial Intelligencesub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorDrug DevelopmentsectorChemistrysectorCore AIsectorSynthetic BiologysectorSpinoutsectorTech for Biotech and PharmasectorBiotech and PharmasectorAI Drug Discovery

Valuation & funding

Arzeda funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
GRANTOther financing Sep 2025 $7.8M US National Science Foundation
LATE VCOther financing Sep 2024 $38M $152M Lewis & Clark Agrifood · Bunge Ventures · Conti Ventures · W.L. Gore & Associates
LATE VCOther financing Nov 2023 $15M $165M Undisclosed
SERIES BOther financing Mar 2022 $33M $132M Casdin Capital · Universal Materials Incubator · Circulate Capital · Lewis & Clark Agrifood
SERIES BOther financing Nov 2020 $6M $24M Sahsen Ventures
FundingOther financing Jan 2020 Undisclosed
SERIES AOther financing Nov 2017 Bioeconomy Capital Sustainable Conversion Ventures · Universal Materials Incubator · OS Fund · WRF Capital
SERIES AOther financing Jul 2017 OS Fund
GRANTOther financing Feb 2015 US National Science Foundation
GRANTOther financing Sep 2013 Undisclosed
Showing 10 recorded eventsUnlock the complete deal history →

Growth signals

Arzeda website traffic

Latest recorded traffic for Arzeda is 4K monthly website visits, down 66.7% over the last three months. Arzeda's team grew 11.8% over the past year.

Latest monthly visits4K 3-month web change-66.7% 1-year team growth+11.8%
Monthly website visits117 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Arzeda compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Arzeda's talent

Book a demo to see the people
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

17 investors on Arzeda's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
WRF Capital
US National Science Foundation
Series A 10 investors entered at this stage
OS Fund
Bioeconomy Capital Sustainable Conversion Ventures
Universal Materials Incubator
Sahsen Ventures
Conti Ventures
Casdin Capital
Circulate Capital
Lewis & Clark Agrifood
Bunge Ventures
Bioeconomy Capital
Series B+ 4 investors entered at this stage
W.L. Gore & Associates
Sucden Ventures
Sofinnova Partners
Fall Line Capital
Other known 1 additional known investor
University of Washington

Global footprint

Where Arzeda has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

In the news

Latest news about Arzeda

Recent press, funding announcements, and product moves mentioning Arzeda — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Arzeda

An AI-synthesized read of the highest-engagement posts about Arzeda on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Arzeda’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.